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ABSTRACT  Three  independently-derived,  antifolate-resistant Chinese  hamster  lung  cell  lines 
that exhibit low level increases in dihydrofolate reductase  (DHFR) activity, i.e., three- to fivefotd 
vs. controls,  have  been  compared  with drug-sensitive cells  to determine  relative DHFR gene 
content.  With  a solution  hybridization  technique  that  makes use  of  genomic  DNA  and  a 
cloned  double-stranded  Chinese  hamster  DHFR  cDNA  probe,  it  has  been  found  that  the 
enzyme activity increases are associated with an approximately proportionate amplification of 
DHFR genes. Trypsin-Giemsa staining techniques and hybridizations in situ further show that 
the amplified  DHFR genes are located within abnormally  banding regions  along chromosome 
2q and also suggest that, in each subline, only one chromosome 2 homolog is initially involved 
in the amplification  process. 
The observation that amplification of dihydrofolate reductase 
(DHFR) genes accompanies the overproduction of this enzyme 
in  cultured  mammalian  cells  challenged  with  the  antifolate 
drugs  methotrexate  and  methasquin  has  been  reported  by 
several investigators (1-6). Although primarily studied in an- 
tifolate-resistant  cell  lines  displaying  high  levels  of DHFR 
overproduction (e.g.,  50- to 300-fold),  where  the correlation 
between the amount of enzyme overproduced and the degree 
of gene amplification has been shown to be essentially propor- 
tional, the question of whether low level overproduction of the 
enzyme (e.g.,  three- to fivefold) is also associated with ampli- 
fication of DHFR genes remains open. While there appears to 
be no compeU.ing reason to evoke an amplification mechanism 
as the mode whereby antifolate-resistant cells maintain a low 
level of dihydrofolate reductase overproduction, indirect evi- 
dence that this might be the case has come from cytological 
studies performed by Biedler and her colleagues (7-10) with a 
number of Chinese hamster lung cell lines varying in DHFR 
activity from 2- to 300-fold. 
Initially, using conventional staining techniques (7) and then 
trypsin-Giemsa banding methods (8) to analyze the karyotypes 
of a  large  series  of independently  derived  Chinese  hamster 
sublines,  selected  with  methotrexate  or methasquin,  respec- 
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tively, it was found that specific chromosome abnormalities, 
preferentially associated with one homolog of the chromosome 
2 pair,  were consistently associated with DHFR overproduc- 
tion. In all drug-resistant cell lines with greater than  100-fold 
increases  in  DHFR  activity,  the  chromosome abnormalities 
were manifested as long, usually terminal segments on chro- 
mosome 2q which failed to band in the cross-striational pattern 
expected  with  trypsin-Giemsa  techniques  and  appeared  as 
medium gray, homogeneously staining regions, HSRs (9). 
In those sublines with less than 100-fold increases in DHFR 
activity, the chromosomal abnormalities  revealed themselves 
not as HSRs but as interruptions or disruptions in the normal 
Giemsa  banding  pattern  of chromosome  2q  with  apparent 
additions  or substitutions  by novel, abnormally banded seg- 
ments characteristic of each subline. These regions, like HSRs, 
have  been  termed  "abnormally banding  regions"  and  have 
been suggested to be cytological manifestations of gene ampli- 
fication as originally proposed (10) and later demonstrated (2) 
for HSRs. Recent results of Melera et al.  (3) documenting a 
20-fold DHFR  gene  amplification  in  one  of these  sublines, 
DC-3F/MQ20  (a  50-fold  DHFR  overproducer),  and  in  situ 
hybridization data which indicate that the abnormally banded 
regions in sublines DC-3F/MQ20 and DC-3F/AI  (a 20-fold 
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W.  Melera,  and  B.  A.  Spengler,  manuscript  in  preparation) 
provide  additional  evidence  that  these  regions  do,  in  fact, 
represent sites of gene amplification. It is possible, however, in 
the cases where the increases in DHFR activity are small, i.e., 
2.9-,  3.9-,  and  4.9-fold  in  sublines  DC-3F/MQI0,  DC-3F/ 
MQ31,  and  DC-3F/A55,  respectively,  that  the  abnormally 
banding  regions  develop  not from  amplification  events  but, 
rather,  from chromosomal breaks and rearrangements which 
situate  a  single  DHFR  gene  in  novel  contexts  of flanking 
nucleotide  sequences.  Such  DHFR  gene  relocations  might 
permit increased transcriptional activity at the new loci, thus 
allowing low level DHFR overproduction without increases in 
DHFR gene number. It was of interest, therefore, to establish 
whether DHFR  gene amplification could be demonstrated in 
drug-resistant cell lines which exhibited  low level increases in 
DHFR  activity  and whether the abnormally banding regions 
in the chromosomes of these cells contained DHFR genes. 
MATERIALS  AND  METHODS 
Cell Lines and Chromosome Analysis 
Derivation and phenotypic characterization of the three antifolate-resistant 
sublmes included in this study are detailed elsewhere (7, 8). DC-3F/MQI0 and 
DC-3F/MQ31 were selected by stepwise  increases in drug to a final concentration 
of 1 ~tg/ml of methasquin and exhibit a  117- and 133-fold  increase in resistance 
to  drug.  DC-3F8/A55  was  selected at  a  final concentration  of 5  jag/ml of 
methotrexate and exhibits a 4,455-fold increase in resistance to that antifolate. 
Results of karyotype analysis of the three sublmes included in this study as well 
as of 13 additional independently-derived antifolate-resistant Chinese hamster 
lung cell Lines with higher DHFR levels have been reported (9). Metaphase cells 
were prepared and stained by trypsin-Giemsa banding methods. 
DNA Isolation and Purification 
DNAs were isolated from nuclear pellets obtained from the three antifolate- 
resistant sublines included in this study, essentially as described by Melera et al. 
(3).  Nuclei were suspended in a  buffer of 10 mM Tris-HC1, pH 7.4, 400 mM 
NaC1,  10 mM EDTA containing 100 btg/ml Proteinase-K, lysed by the addition 
of SDS to 0.5% and incubated for 24-36 h at 37°C with gentle agitation. DNA 
solutions were extracted twice with phenol:chloroform:isoamyl  alcohol and high 
molecular weight DNA obtained by spooling. Spooled DNA was pressed free of 
excess ethanol, resuspended in a  buffer of 10 mM Tris HC1 (pH 7.4),  20 mM 
EDTA,  and  incubated for  3  h  at 37°C with 50/~g/ml RNase  A.  The  DNA 
solution was next digested with 100/Lg/ml Proteinase K for 3 h at 37°C after the 
addition  of  NaC1  to  400  raM.  This  digest  was  then  extracted  twice  with 
phenol:chloroform:isoamyl alcohol and, after the addition of 2.5 vol of ethanol, 
the high molecular weight DNA was collected again by spooling, dried under 
vacuum, and rcsuspended in 100 mM NaAc, pH 7~0. 
DNA Shearing and Chelex Treatment 
High molecular weight DNA was reduced to 350-400 base pair (bp) fragments 
by shearing in a Virtis Model 60 homogenizer essentially as described by Britten 
et al. (11).  DNA solutions in 100 mM NaAc- pH 7.0 were adjusted to 66% vol/ 
vol glycerol and sheared at 54,000  rpm for 30 rain at 0-4°C. After the addition 
of NaAc- to 0.3 M, DNA was precipitated from 2-5 vol of 95% ethanol at -20°C 
for  18-24  h,  collected by  centrifugation,  and  sized  by  alkaline agarose  gel 
electrophoresis, according to  McDonnell et al.  (12),  using Hae  III digests of 
q~X174 as molecular weight markers. DNA preparations were then resuspended 
into  100 mM NaAc-, pH 7.4, and treated with Bio-Rad Chelex 100 (Bio-Rad 
Laboratories, Richmond, CA) by batch procedures. Up to 20 mg of DNA were 
treated with 2.5 ml of packed Chelex previously equilibrated to pH 7.4 in 100 
mM NaAc-. 
pDHFR6 Insert Purification and Nick Translation 
The 650 bp DHFR-specific insert of pDHFR6 (13), cloned into pBR322 with 
Eco RI and Sal I linkers, was isolated by electropboresis through native 1.5% 
agarose gels after the digestion ofpDHFR6 with Eco RI and Sal I enzyme. Insert 
DNA  was located  in  the  ethidium bromide-stained gel (5  ~g/ml)  by  U.V. 
illumination, and a section of the gel containing the insert was enclosed in dialysis 
tubing and electroeluted over a 3-h period. DNAs were concentrated by DEAE- 
Sephacel chromatography and ethanol precipitation. The recombinant insert was 
nick-translated with ~2p dXTPs  essentially as described by Rigby et al. (14). 
Specific activities ranged from 3 to 7  ×  107 cpm/#g, depending on the DNA 
preparation. DNAs radiolabeled by this protocol had an average molecular size 
0f250 bp as determined by alkaline gel electrophoresis (12) with Hae III digests 
of fiX174 as molecular weight standards. Snapback DNA generated by Esche- 
richia coil Pol I during nick translation was removed as follows. The labeled 
probe was heat-denatured,  reassociated to  a  Cot  of  10  -4  and fractionated by 
hydroxylapatite  (HAP)  chromatography.  The  sequences  remaining  single- 
stranded through this period were recovered in 0.12 M NaPO4 and were capable 
of reassociation to >92% at Cot 10  -1 when reanalyzed. 
Reassociation Analysis and 
HAP Chromatography 
Sheared genomic DNAs were resuspended in a hybridization buffer of 0.14 M 
NaPO4,  pH  6.8,  0.1%  SDS  as described by Sambrook et al. (15).  250 ~tg of 
genomic DNA was combined with 0.05 lag of pDHFR6 insert (3,500 cpm a2p) in 
a 100 #1 reaction and heat denatured by boiling. Reactions were brought to 60°C, 
adjusted to  1.0 M  NaC1,  and incubated at 60°C. At appropriate times, 25-#1 
aliquots of the main reaction were withdrawn, diluted to 1.0 ml in 0.12 M NaPO4, 
quick-frozen, and held at -20°C until assay by HAP chromatography. Individual 
samples were chromatographed on Bio-Rad HTP hydroxyapatite columns pre- 
pared in Pasteur pipettes plugged with silanated glass wool. Mulliple samples 
were processed simultaneously in a circulating water bath maintained at 60°C. 
Single-stranded DNAs  were eluted in  5-colunm volumes of 0.12  M  NaPO4. 
Double-stranded DNAs were eluted in  5-colunm volumes of 0.5  M  NaPO4. 
Aliquots of both fractions were mixed with 2.0 vol of Biofluor (New England 
Nuclear, Boston, MA), cooled to 4°C, and quantified by scintillation counting. 
In Situ Hybridization 
Metaphase plates for hybridization studies were prepared by standard proce- 
dures after exposure to @1-0.5  #g/ml colcemid for 4-6 h. After digestion with 
ribonuclease A, cellular DNA was denatured in 0.07 N  NaOH, twice SSC (0.15 
M sodium chloride and 0.015 M sodium citrate, pH 7.0), for 2-3 rain at ambient 
temperature. The hybridization mixture contained 50% formamide, four times 
SSC,  pH 7.0,  10% sodium dextran sulfate 500, once Denhardt's reagent (0.02% 
wt/vol bovine serum albumin, polyvinyl  pyrrolidone, and Ficoll, Mr = 400,000), 
0.1  M  potassium iodide, 100 #g/ml denatured salmon sperm DNA, and either 
35-70 ng/ml or 7 btg/ml of nick-translated, [~25I]-labeled pDHFR6 probe (sp act 
2 to 9 ×  10  e DPM/#g). Slides with 8-10 tzl of the hybridization mixture under 18- 
mm  2 cover glasses were incubated in moist chambers (16) at 37°C for 6 to 18 h. 
Preparations were washed at 37°C in three changes of four times SSC, pH 7.0, 
for 10 min each, in once Denhardt's solution for 1 h, and in six additional rinses 
of four times SSC for a total of 18-20 h, dehydrated in ethanol, and air-dried. 
Slides were dipped in Kodak NTB-2  liquid emulsion diluted  1:1  with water, 
exposed at 4°C for 7 d to 4 ran, developed in Kodak D-19 developer, and stained 
in a 1:50 dilution of Giemsa's. Additional experimental  details are given elsewhere 
(J. L. Biedler, P. W. Melera, and B. A. Spengler, manuscript in preparation). 
RESULTS 
Representative  G-banded  metaphase  ceils  of the  antifolate- 
resistant sublines DC-3F/MQI0,  DC-3F/MQ31,  and DC-3F/ 
A55 with abnormally banding regions on chromosome 2q are 
shown in Fig.  1. These cell lines, overproducing  DHFR  2.9-, 
3.9-,  and 4.9-fold,  respectively,  have abnormal regions which 
are 0.74,  2.2,  and  0.62  times,  respectively,  the  length  of the 
short (p) arm of the affected number 2  chromosome (9). The 
abnormal banding pattern can be seen to be highly cell line- 
specific (Fig.  1). Although these sublines are marked by addi- 
tional, apparently random, structural chromosome rearrange- 
ments, as previously detailed (7-9), none of the latter resemble 
the long chromosomal regions with clearly abnormal, uniden- 
tifiable  bands  preferentially  located  on  chromosome  2q.  It 
should  be  noted  that  sublines  DC-3F/MQ10  and  DC-3F/ 
MQ31  are  near-tetraploid,  whereas  subline  DC-3F/A55  is 
near-diploid. Of interest here is the observation that two of the 
four chromosome 2  homologs  in  the  DC-3F/MQ31  subline 
contain abnormally banding regions, whereas  only one of the 
LEWIS  ET  AL.  Gene Amplification in Chinese Hamster Lung Cells  419 FIGURE  1  G-banded metaphase cells. Abnormally banding regions are indicated by brackets. Arrows  indicate the wide, palely 
staining  band  8  of  chromosome  2q  (9).  (a)  Subline  DC-3F/MQ10.  Cells  have a  modal  chromosome  number  of  42  (8)  and 
consistently contain three normal chromosome 2's, as indicated, and one abnormal homolog with an abnormally banding region 
comprising most of the 2q arm. (b) Subline DC-3F/MQ31. The modal chromosome number is 39 or 40 (8). Cells have two normal 
chromosome  2's  and  a chromosome consisting  of  a  normal  2)o arm.  A  fourth  2p arm  is  not  present.  The  other 2q  arms  are 
recognizable as distinctive segments comprising bands 7 and 8  (9),  bound on one or both ends by abnormally banding regions, 
and translocated to a normal 5q.  (Chromosome 5 was designated a 6  in our previous publications.)  Almost every cell  has two 
versions of the same abnormal chromosome. In this cell the distal half of the longer chromosome with  the abnormally banding 
region is  identical to the abnormal  region of  the shorter chromosome.  This cell  has  possible double minute  chromosomes  (at 
center of cell), a rare finding  in antifolate-resistant Chinese hamster lung cells.  (c)  Subline DC-3F8/A55.  This line has a modal 
chromosome number of 22 and an abnormally banding region located interstitially on the long arm of a single chromosome 2. x 
1,500. four does so in DC-3F/MQI0. As described in the legend to 
Fig.  1, the two abnormal chromosomes in DC-3F/MQ31  are 
essentially identical. Only one chromosome 2 homolog in the 
DC-3F/A55 subline contains an abnormally banding region, 
just as observed in all the other diploid lines we have examined. 
Since none of the abnormally banding regions found among 
our 17 drug-resistant sublines have the same appearance, it is 
highly unlikely that two of the four chromosome 2 homologs 
in subline DC-3F/MQ31 independently acquired identical ab- 
normally banding regions. We suggest, therefore, that the two 
abnormally banded homologs are present because the cell line 
acquired the abnormally banding region before tetraploidiza- 
tion  occurred.  It  also  follows  that  the  abnormally  banding 
region on the single chromosome 2 homolog in subline  DC- 
3F/MQI0  must  have  occurred  after  tetraploidy  was  estab- 
lished,  since,  had  it  occurred  before,  two  homologs of the 
tetraploid cell would be affected. The discriminatory nature of 
the  mechanism  in  these  cell  lines  which  apparently  limits 
involvement of more than one chromosome 2 homolog in the 
acquisition of abnormally banding regions is not understood. 
To  establish  whether  DFHR  gene  amplification  had  oc- 
curred in the antffolate-resistant sublines with small increases 
in DHFR activity, the 650 bp DHFR specific double-stranded 
DNA insert of the recombinant plasmid pDHFR6 was isolated, 
labeled  in  vitro  by nick  translation  and  reacted  in  solution 
hybridization with genomic DNAs from either the control DC- 
3F cell line or the cell lines DC-3F/MQ10, DC-3F/MQ31, and 
DC-3F/A55.  The  kinetics  of hybridization  were  analyzed 
mathematically according to the equations detailed  by Sam- 
brook et al. (15). 
The self-reassociation of the labeled DHFR probe was first 
established  by hybrid  formation in  the presence  of sheared 
salmon  sperm  DNA.  250  /zg  of salmon  sperm  DNA  was 
combined with 0.05  ng of probe, heat-denatured and hybrid- 
ized at 60°C. At various times aliquots of the main reaction 
were  withdrawn  for  analysis  of hybrid  formation  by  HAP 
chromatography. At each time point a solution of the equation 
1/f,  =  t/tE/2 +  1 (where f, is the fraction of probe remaining 
single-stranded and t is the time of reannealing) gave a value 
for tx/2, the time required for one half of the probe sequences 
to be in DNA duplex.  Determination of the tel2 at each time 
point throughout the course of the reaction yielded an average 
t~/2 value of 6.33 + 0.67 h (see Table I, Probe alone). When the 
labeled  probe was reacted in the presence of genomic DNA 
containing homologous DHFR sequences, its reassociation was 
accelerated  to  a  degree  dependent  on  the  concentration  of 
homologous  sequences  supplied  in  the  genomic  DNA.  As 
expected, the reassociation of  the DHFR probe was accelerated 
in the presence of genomic DNA from control drug-sensitive 
DC-3F cells,  as reflected by the reduced average tl/2 value of 
2.67  _+ 0.19  h  (Table I). This value for t~/2 in the presence of 
DC-3F was then compared with the ti/= values determined by 
the reassociation of the probe in the presence of the genomic 
DNAs from each of the three DHFR-overproducing sublines. 
In each case (Table  I),  the reassociation  rate  of the labeled 
DHFR probe in the presence of resistant  subline  DNA was 
accelerated relative to its rate of reassociation in the presence 
of DC-3F DNA, thus demonstrating the presence of increased 
numbers of DHFR genes in drug-resistant cells. The tl/2 values 
were reduced to 0.91 +  0.14, 0.82 +  0.13, and 1.26 +  0.11 h by 
reaction with DC-3F/MQ 10, DC-3F/MQ3 l, and DC-3F/A55 
genomic DNA, respectively.  These accelerated  kinetics were 
revealed graphically  by an increase  in the slope of the line 
drawn by a plot of the l/f, values for each time point for each 
DNA against the  1/tE/2 values established  at each time point 
for the reassociation of the probe sequences in the presence of 
salmon sperm DNA (Fig. 2). Using the t1/2 values established 
in the presence ofDC-3F DNA, the relative increases in DHFR 
gene number in the DC-3F/MQI0, DC-3F/MQ31, and DC- 
3F/A55 cell lines were estimated by the ratio tx/2 sensitive cell 
DNA/tl/2  resistant cell DNA, and are presented in Table II. 
As  with  our  previous  results  using  sublines  overproducing 
DHFR  100-fold or more (3), the relative increases in DHFR 
gene copy number in these three sublines were approximately 
equal to the relative increases in their DHFR activity. 
Identification of the chromosomal sites of amplified DHFR 
genes  in  the  DC-3F/MQI0  and  DC-3F8/A55  sublines  was 
made by hybridization in situ using nick-translated pDHFR6 
as  probe  (Fig.  3).  In each  case  the  autoradiograms  showed 
clusters of grains specifically associated with those regions of 
chromosome 2q known to be abnormally banding (see Fig. 1), 
while the remainder of the chromosomes were free of consistent 
grain clusters. Although a more quantitative treatment of these 
data will appear elsewhere (J. L. Biedler, P. W. Melera, and B. 
A.  Spengler,  manuscript  in  preparation),  they serve  here  to 
show that the majority, if not all, of the amplified DHFR genes 
demonstrated to exist in these sublines (Table II) are contained 
within  the  abnormally  banding  regions  of chromosome 2q. 
Assuming that the diploid parental cell line DC-3F contains 
two copies of the  DHFR gene,  one on each chromosome 2 
homolog to which the native Chinese hamster DHFR gene has 
tentatively been assigned (17),  it can be determined from the 
data  of Table  II that  sublines  DC-3F/MQ10  and  DC-3F/ 
MQ31 each contain twelve copies of the DHFR gene and that 
subline  DC-3F/A55  contains  four  copies.  The  abnormally 
banding region in the tetraploid subline DC-3F/MQ10, there- 
fore,  contains  nine  DHFR  genes  with  the  remaining  three 
copies of the gene present  at one copy per normal homolog. 
TABLE I 
Renaturation of 32p-labeled Recombinant Insert of pDHFR 6 in the Presence of Genomic DNA from the Control DC-3F Cell Line or 
the Resistant Lines  OC-3F/ MQTO,  DC-3F/ MQ31, and OC-3F8/ A55 
tl/2  * 
Time  (h)$  1  2  3  4  5  7  Average value 
Probe alone  5.44 ±  0.44  5.71  6.63 ±  0.51  6.55  6.95 ±  0.29  6.70  6.33 +  0.67 
DC-3F  2.50 +  0.0  2.35  2.85 ±  0.15  2.79  2.82 ±  0.12  2.72  2.67 _  0.19 
DC-3F/MQ10  0.68 ±  0.04  0.81  0.97 ±  0.03  1.00  1.06 ±  0.11  0.95  0.91 ±  0.14 
DC-3F/MQ31  0.67 ±  0.04  0.70  0.91  ±  0.09  0.83  0.95 ±  0.22  0.86  082 ±  0.13 
DC-3F8/A55  1.06 ±  0.02  1.28  1.30 ±  0.0  1.33  1,29 +  0.04  1.33  1.26 ±  0.11 
* tl,~ =  the time  required for the  DHFR  probe to be 50% reassociated  by reaction  with genomic  driver DNA. Values  for t'~  are computed accordin 8 to the 
equation 1/f~ =  t/tl/2 +  1, where fss is the fraction of probe remaining single-stranded  and  t is the time of sample  incubation. 
$ Each 1-, 3-, and 5-h value represents  the average from two separate experiments. The 2-, 4-, and 7-h values represent  single determinations. 











0.2  0.4  0.6  0.8  1.0  1.2 
FIGURE  2  Renaturation  of  a2P-labeled  recombinant  insert  of 
pDHFR6 in the presence of genomic DNA from  the DC-3F control 
line or the resistant lines DC-3F/MQI0, DC-3F/MQ31, and DC-3F8/ 
A55.  0.05  ng  recombinant  insert  of  pDHFR6  nick-translated  to  a 
specific activity of 7.7 x  107 s2p cpm/#g was heat-denatured in the 
presence of 250 #g genomic DNA, cooled to 60°C and hybridized 
for various times in a buffer of 0.14 M  NaPO4, 1.0 M  NaCI, 0.1% SDS 
in a total reaction volume of 100 p,l. Aliquots of the main reaction 
were withdrawn at the appropriate times and quick-frozen in 1.0 ml 
0.12  M  NaPO4  and  held  at  -20°C  until  fractionation  by  HAP 
chromatography. Aliquots of both  HAP fractions were mixed with 
Biofluor and quantified by scintillation counting• The renaturation 
of the probe alone was conducted in the presence of 250 #,g salmon 
sperm DNA sheared to 400 bp. All genomic DNAs were sheared to 
400 bp before analysis.  The data shown was obtained from Table l, 
as described in  the text. (a)  Probe alone.  (b)  DC-3F.  (c)  DC-3Fg/ 
A55.  (d)  DC-3F/MQI0.  (e)  DC-3F/MQ31. 
TABLE  II 
Genomic DHFR Gene Complements of the Resistant Cell Lines 
DC-3F/ MQIO,  DC-3F/ MQ31,  and  DC-3FS/ A55 Estimated by 
the Ratio: tl/2 Sensitive Ceil DNA "/tl/2  Resistant Cell DNA 
DHFR gene equiv-  Increase in DHFR 
alents:l: relative to  activity relative to 
Cell line  the DC-3F  line  the DC-3F  line§ 
DC-3F/MQ10  2.95 ±  0.02  2.9 
DC-3F/MQ31  3.27 __. 0.12  3.9 
DC-3F8/AS5  2~15 ±  0.0  4.6 
*  tl/2 is the time  required for  50% hybridization  of the  recombinant insert 
probe, computed according to the equation 1/f~ =  t~ tl/2 + 1 (15), where fss 
is the fraction single stranded and  t is the time of sample incubation. 
:}:Since equal amounts of genomic DNA were used in  these hybridization 
experiments, the data do not discriminate between diploid and tetraploid 
nuclear DNA contents. Hence, the near-tetraploid lines DC-3F/MQ10 and 
DC-3F/MQ31 actually contain approximately six times more DHFR gene 
copies per cell than the near-diploid control line DC-3F. The value listed is 
the average  obtained from two separate  experiments. 
§ Data taken from Biedler et aL (9). 
The abnormally banding region  in  the  near-diploid  subline 
DC-3F/A55  contains  three  copies  of the  DHFR  gene,  the 
fourth copy resident  on the single normal homolog. Although 
we have not done hybridizations  in situ with subline  DC-3F/ 
MQ31,  we assume both of the abnormally banding homologs 
in this near-tetraploid  line to each contain five DHFR gene 
copies, and the two normal homologs to contain one copy each. 
FIGURE  3  Hybridization  of  radiolabeled  pDHFR6  to  metaphase 
chromosomes. (a) Subline DC-3F/MQI0.  Bracket delineates a clus- 
ter of  silver grains over a  region corresponding  in  size and  chro- 
mosomal location to the abnormally banding region depicted in Fig. 
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I  a. (b) Subline DC-3F8/A55. Bracket indicates a grain cluster on the 
probable chromosome 2 with the abnormally banding region. Grains 
are located over a region corresponding to the constricted, central 
region  of  the  chromosome  arm  (Fig.  I  c)  and  not  the  proximal 
abnormally banding portion• Arrow indicates a probable contami- 
nant grain cluster unique to this cell. 1750x magnification. Hybridization in  situ of another near-tetraploid subline, DC- 
3F/MQ20, containing two identical abnormally banding hom- 
ologs,  has shown that  both contain amplified DHFR genes 
08). 
DISCUSSION 
The hybridization kinetic data presented here show that three 
independently  derived  antffolate-resistant  Chinese  hamster 
lung cell lines exhibiting low level increases in DHFR activity, 
i.e.,  three  to  five  times  that  of controls,  contain  amplified 
DHFR genes. Since in each case these genes are present within 
abnormally banding regions of chromosome 2q, it is not pos- 
sible to estimate what effect,  if any, chromosomal rearrange- 
ments may have on  DHFR gene expression.  However, and 
although  the  formal possibility exists  that  not  all amplified 
genes  are  transcribed,  the  correlation  between  the  relative 
DHFR gene copy number and the relative amount of DHFR 
activity (Table II), coupled  with  other data  (19, and  P.  W. 
Melera, C. A. Hession, J. P. Davide, K. W. Scotto, J. L. Biedler, 
M.  B.  Meyers,  and  S.  Shanske,  manuscript  submitted  for 
publication)  which  shows  that  the  measured  increases  in 
DHFR activity in these cells is associated with actual increases 
in the amount of enzymes present, strongly suggest that ampli- 
fication of DHFR gene number is the predominant factor in 
regulating the level of DHFR activity in these drug-resistant 
sublines.  Similar results have recently been reported by Kauf- 
man and  Schimke (20)  who have shown via Southern  blots 
that  Chinese  hamster ovary (CHO)  cells  selected  with  low 
concentrations of methotrexate (MTX) and overproducing low 
levels of DHFR,  also contain  increased  numbers of DHFR 
genes. The failure in both cases to identify cell lines containing 
promoter-type mutations is of genetic interest,  and although 
the sampling size  is small, may reflect the greater frequency 
with which amplification mutants occur vs.  point mutations 
which affect promoter efficiency.  Indeed a single point muta- 
tion may not be effective in modifying the efficiency in vivo of 
the apparently large promoter regions associated with eukar- 
yotic genes (21) and would, therefore, not be detected. 
The presence of DHFR genes within the abnormally banding 
regions of chromosome 2q  equates these  regions,  insofar as 
they indicate the location of amplified DHFR genes, with the 
HSRs  found  on  chromosome 2q  in  cells  that  overproduce 
DHFR by more than 100-fold. HSRs are regarded as uniformly 
packaged tandem repeats of amplified DNA. Estimates of the 
size of these repeats, i.e., the size of the amplification unit, have 
been made by dividing the amount of DNA within an HSR 
(estimated from chromosomal length determinations)  by the 
total number of DHFR gene copies present in the cell.  The 
primary assumptions are that all the amplified genes are in the 
HSR, that all amplification units within an HSR are the same 
size,  and  that the  packing ratio  of DNA within  an HSR is 
similar to that of the normal chromosomes. Several estimates 
have predicted that for CHO (2) and mouse cell lines (4, 5), the 
amplification unit contains ~500-3,000 kilobase pair (kbp) of 
DNA.  However,  an  estimate of 135  kbp  has  recently been 
reported for a  CHO line  containing  700-1,000  DHFR gene 
copies (6). Assuming the Chinese hamster lung cell genome to 
contain 2 x  109 bp of DNA and the diploid parental cell line 
DC-3F  to  contain  two  copies  of the  DHFR  gene,  we  can 
calculate an amplification unit  size  of ~300  to 700  kbp for 
several of our sublines in which HSR length (9)  and DHFR 
gene copy number (3)  are known.  If similar calculations are 
made  for  sublines  containing  abnormally  banding  regions, 
however, extremely large unit sizes result, DC-3F/MQ31 being 
the largest and containing 35,800  kbp of DNA, followed by 
DC-3F/A55 with 17,700 kbp of DNA, and DC-3F/MQ 10 with 
7,066 kbp of DNA per unit. 
In addition to these bewildering estimates of size, no obvious 
correlation exists between the length of an abnormally banded 
region and the number of DHFR genes within it. For example, 
the  abnormally banded  segment  of DC-3F/MQ31  is  three 
times the size of that in subline DC-3F/MQ10 (9), yet DC-3F/ 
MQ31 is estimated to contain five DHFR genes per abnormally 
banded region while DC-3F/MQ 10 contains nine (see Results). 
A  similar comparison  between  sublines  DC-3F/MQ31  and 
DC-3F/MQ20 reveals that abnormally banded regions of the 
same size, i.e., approximately twice the length of chromosome 
2p (9), can contain widely different numbers of DHFR genes, 
e.g., the abnormally banded region of DC-3F/MQ31 contains 
five DHFR genes while that in subline DC-3F/MQ20 contains 
20 to 40 (3). Apparently, therefore, DHFR gene copy number 
and abnormally banding region size can vary independently, 
the magnitude of one having little or no effect on the other. 
Since,  in all cases, the abnormally banding regions represent 
the locations of amplified DHFR genes,  these discrepancies 
may conceivebly result from wide variations in the size of the 
DHFR gene amplification unit.  Alternatively, however, and 
perhaps more likely considering the estimated sizes of these 
units, abnormally banding regions may contain, in addition to 
amplified DHFR genes,  other amplified sequences  and  dis- 
rupted chromosome 2q DNA resulting from multiple insertions 
of varied DNA sequences along chromosome 2q in sufficient 
amounts to disrupt normal banding patterns. Such disruptions 
in  banding  pattern  have  been  reported  to  accompany  the 
integration of transforming DNA into host cell chromosomes 
(22). If DHFR gene amplification proceeds by a mechanism 
which  includes  an  extrachromosomal phase  through  which 
copies of the DHFR gene (18, 23) and other DNA sequences 
pass, followed by integration of these sequences at various sites 
along chromosome 2q,  then disruptions  to banding patterns 
similar  to  those  resulting  from  integration  of transforming 
DNA could result. This would help to explain why abnormally 
banding regions and HSRs have been found to be located at 
many different sites along chromosome 2q (18). 
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